Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Suitability of an Infant Formula Manufactured From Extensively Hydrolysed Protein in Healthy Term Infants

NCT04736082 is registered in ClinicalTrials.gov with HiPP GmbH & Co. Vertrieb KG as lead sponsor.

NCT NCT04736082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04736082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Suitability of an Infant Formula Manufactured From Extensively Hydrolysed Protein in Healthy Term Infants
Lead sponsor
HiPP GmbH & Co. Vertrieb KG
Phase
Not applicable
Overall status
Completed
Start date
March 16, 2021
Completion date
October 27, 2021
Enrollment
360 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

growth